Typicality: | 0.413 |
Saliency: | 0.322 |
for optimal effects | 4 | purpose |
with each other | 3 | other |
with rifampin against a. baumannii | 2 | transitive-object |
compound → work in → synergy | 8 |
compound → act in → synergy | 7 |
negative | neutral | positive |
0.076 | 0.432 | 0.491 |
Raw frequency | 15 |
Normalized frequency | 0.322 |
Modifier score | 0.850 |
Perplexity | 296.637 |